News & Updates
Filter by Specialty:
Earlier anti-TNF-α medication helps ensure treatment success in paediatric IBD
First-line treatment with tumour necrosis factor-α (TNF-α) blockers is both safe and effective in children with inflammatory bowel disease (IBD), according to a recent study. Early drug initiation even cuts the likelihood of treatment failure and leads to fewer extraintestinal symptoms.
Earlier anti-TNF-α medication helps ensure treatment success in paediatric IBD
02 Aug 2022
Antenatal vitamin D supplementation may curb risk of infant eczema
Infants born to mothers who popped vitamin D during pregnancy are less likely to develop atopic eczema compared with their counterparts whose mothers received placebo, as shown in the UK Maternal Vitamin D Osteoporosis Study (MAVIDOS).
Antenatal vitamin D supplementation may curb risk of infant eczema
01 Aug 2022
White matter diminished in ASD teens born premature
In adolescents and young adults who screen positive for autism spectrum disorder (ASD), magnetic resonance imaging (MRI) reveals strong reductions in white matter, a new study has found.
White matter diminished in ASD teens born premature
29 Jul 2022
Paternal IBD medication use before conception carries no excess risk of childhood infections
Fathers’ exposure to anti-inflammatory or immunosuppressive medications for inflammatory bowel disease (IBD) prior to conception does not appear to contribute to a significantly increased risk of childhood infections, a study has found.
Paternal IBD medication use before conception carries no excess risk of childhood infections
28 Jul 2022
Maternal vaccination reduces COVID-19 hospitalization risk in offspring
Full vaccination (two doses) with an mRNA COVID-19 vaccine during pregnancy was associated with a reduced risk of COVID-19-related hospitalization among infants younger than 6 months of age, according to a recent study.